Recombinant SARS-CoV-2 Spike Protein, S1 Subunit, Host Cell Receptor Binding Domain (RBD)
Recombinant SARS-CoV-2 Spike Protein, S1 Subunit, Host Cell Receptor Binding Domain (RBD) derived from E.coli
Product Description
Specifications
| Size | 100 ug, 500 ug, 1000 ug |
|---|---|
| Species | SARS-CoV-2 |
| Accession Number | QHD43416 |
| Protein Name / Synonyms | SARS-CoV-2 Spike Protein, S1 Subunit, S protein, spike protein |
| Expressed Region | Arg319 - Phe541 |
| Expression System | E. coli |
| Tag | N-terminal histidine tag |
| Purification | His-tag affinity purification by immobilized metal ion affinity chromatography (IMAC) |
| Purity | >95 % |
| Purity Determined By | SDS-PAGE under reducing conditions and visualized by Coomassie blue staining |
| Molecular Weight (kDa) | ∼25 kDa |
| Format | Liquid |
| Formulation | Filtered solution in 50 mM Na2HPO4 (pH 7.4), 0.5 M NaCl, 450 mM imidazole, 6 M urea. |
| Concentration (lot specific) | Lot specific (see the label on the vial), determined by Bradford protein assay. |
| Estimated Lead Time | 1-2 business days |
| Shipping Type | Blue ice |
| Storage | -20°C |
Suzuki YJ, et al. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells. Vascul Pharmacol, 137 (2021).
Yu J, et al. Direct activation of the alternative complement pathway by SARS-CoV-2 spike protein is blocked by factor D inhibition.?Blood. 2020 Sep 2;blood.2020008248 (2020).
Write Your Own Review